Larimar Therapeutics, Inc. (LRMR)

Last Year

22-Nov-23 -- 21-Nov-24

Time Period:

$38.00M Net Amount

Buy:	$38.00M	$8.74
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Buy

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

16

0

5

+1

0

+2

2

+3

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-Feb-24 4:21 PM View:	14-Feb-24 Purchase $22.00K	Thomas Frank E Director		Larimar Therapeutics, Inc. - LRMR	100% 0 to 2.0K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 4:32 PM View:	17-Jan-24 Grant 0	Celano Michael Chief Financial Officer		Larimar Therapeutics, Inc. - LRMR	28% 112.75K to 144.0K	0	0	--	--	Show Txns Hide Txns

31-May-24 4:56 PM View:	16-Feb-24 Market Purchase $500.00K	Hamilton Thomas Edward Director		Larimar Therapeutics, Inc. - LRMR	9% 667.02K to 724.23K	$500.00K 9%	0	$8.74	--	Show Txns Hide Txns

19-Jan-24 4:31 PM View:	17-Jan-24 Grant 0	Ben-Maimon Carole President and CEO Director		Larimar Therapeutics, Inc. - LRMR	25% 266.83K to 332.95K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 2:37 PM View:	16-Feb-24 Market Purchase $37.50M	Flynn James E Director 10% Owner		Larimar Therapeutics, Inc. - LRMR	25% 16.94M to 21.23M	$37.50M 25%	0	$8.74	--	Show Txns Hide Txns

19-Jan-24 4:33 PM View:	17-Jan-24 Grant 0	Shankar Gopi Chief Development Officer		Larimar Therapeutics, Inc. - LRMR	100% 0 to 27.5K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 4:31 PM View:	17-Jan-24 Grant 0	Clayton Russell Chief Medical Officer		Larimar Therapeutics, Inc. - LRMR	100% 0 to 22.5K	0	0	--	--	Show Txns Hide Txns